Compare TRLV & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRLV | ECAT |
|---|---|---|
| Founded | N/A | 2021 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2021 | 2021 |
| Metric | TRLV | ECAT |
|---|---|---|
| Price | $9.69 | $15.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 741.5K | 510.1K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | ★ 26.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,181,180,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.32 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.82 | $13.36 |
| 52 Week High | $10.15 | $16.84 |
| Indicator | TRLV | ECAT |
|---|---|---|
| Relative Strength Index (RSI) | 60.22 | 62.81 |
| Support Level | $8.22 | $14.93 |
| Resistance Level | $10.15 | $15.98 |
| Average True Range (ATR) | 0.55 | 0.16 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 88.46 | 92.92 |
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.